STOCK TITAN
  1. Home
  2. Sec-filings
  3. INCY
  4. [144] INCYTE CORP SEC Filing

Incyte (INCY) insider Pablo Cagnoni plans 10,640-share sale under Form 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Incyte Corporation affiliate Pablo Cagnoni filed a Form 144 indicating an intention to sell up to 10,640 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ, with a stated aggregate market value of $1,305,450.33 as of the filing.

The filing also notes that these shares were acquired on June 1, 2026 as restricted stock and performance shares from the issuer, and discloses that 15,888 shares of common stock were sold on July 31, 2026 for $1,901,833.32 during the prior three months. Shares outstanding are listed as 202,697,746.

Positive

  • None.

Negative

  • None.
Proposed shares to be sold 10,640 shares Common stock proposed for sale under Form 144
Aggregate market value of proposed sale $1,305,450.33 Valuation associated with 10,640 shares of common stock
Shares outstanding 202,697,746 shares Common shares outstanding referenced in the Form 144
Prior 3-month shares sold 15,888 shares Common stock sold on July 31, 2026
Value of prior sale $1,901,833.32 Proceeds from 15,888-share sale on July 31, 2026
Acquisition date of shares 06/01/2026 Date restricted stock and performance shares were acquired from issuer
Form 144 regulatory
"filed a Form 144 indicating an intention to sell"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Restricted Stock financial
"acquired as restricted stock and performance shares from the issuer"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
Performance Shares financial
"acquired as restricted stock and performance shares from the issuer"
Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.
aggregate market value financial
"associated with an aggregate market value of $1,305,450.33"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

FAQ

What does the Form 144 filing by INCY’s Pablo Cagnoni disclose?
The Form 144 filing discloses a proposed sale of up to 10,640 shares of Incyte common stock. It also reports a prior sale of 15,888 shares on July 31, 2026, providing transparency into recent and planned insider-related transactions.

How many INCY shares does Pablo Cagnoni plan to sell under this Form 144?
The filing indicates an intention to sell up to 10,640 shares of Incyte common stock. These shares are associated with an aggregate market value of $1,305,450.33, based on the valuation used in the Form 144 disclosure.

What prior INCY stock sales are reported in Pablo Cagnoni’s Form 144?
The Form 144 reports that on July 31, 2026, 15,888 shares of Incyte common stock were sold for $1,901,833.32. This disclosure covers securities sold during the past three months, as required for Form 144 filings.

How were the INCY shares in the planned Form 144 sale originally acquired?
The shares were acquired on June 1, 2026 as restricted stock and performance shares from the issuer. This indicates they originated from issuer-related equity awards rather than open-market purchases.

What does the Form 144 say about INCY’s total shares outstanding?
The filing lists 202,697,746 shares of Incyte common stock as outstanding. This figure serves as a reference baseline for understanding the scale of the proposed and prior insider-related share sales disclosed in the Form 144.

Through which broker and market will the INCY Form 144 shares be sold?
The proposed sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ market. This information is taken from the securities information section of the Form 144 filing.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR